Tuberculosis Cutis Indurativa, also known as Lupus vulgaris or tuberculosis of the skin, is a chronic and progressive skin condition caused by the tuberculosis bacterium, Mycobacterium tuberculosis. It is a rare manifestation of tuberculosis that primarily affects the skin and surrounding tissues.
The disease is characterized by painless, nodular or ulcerative skin lesions that often occur on the face, extremities, or any exposed body parts. These lesions are typically red or brown in color and are accompanied by thickening and hardening of the affected skin. Over time, the lesions may enlarge and become more prominent, eventually leading to the destruction of skin tissue and underlying structures.
Tuberculosis Cutis Indurativa is usually a result of the spread of tuberculosis from a primary site of infection elsewhere in the body, such as the lungs or lymph nodes, to the skin. It is more common in individuals with weakened immune systems, such as those with HIV/AIDS or malnutrition.
Diagnosis of Tuberculosis Cutis Indurativa involves a comprehensive evaluation of the patient's medical history, clinical examination, and laboratory tests including skin biopsies and cultures to identify the presence of Mycobacterium tuberculosis.
Treatment options for Tuberculosis Cutis Indurativa often involve a combination of pharmacological therapies, including antitubercular drugs and antibiotics, to eliminate the tuberculosis infection. In some cases, surgical intervention may be necessary to remove extensive lesions or to repair damaged skin tissue.
Overall, Tuberculosis Cutis Indurativa is a chronic and debilitating skin condition caused by the tuberculosis bacterium that requires early diagnosis and appropriate treatment to prevent further complications and spread of the infection.
